Insulin-like growth factor-1 receptor expression in thymic malignancies
Nicolas Girard1, Julie Teruya-Feldstein, Eden C Payabyab
1Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York City, NY 10065, USA.
Summary
Most thymic malignancies show moderate to high insulin-like growth factor-1 receptor (IGF-1R) expression. This suggests potential for anti-IGF-1R therapies in treating these rare cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Thymic epithelial tumors are rare, aggressive mediastinal malignancies.
- Insulin-like growth factor-1 receptor (IGF-1R) plays a role in cell growth and survival.
- Elevated IGF-1R expression may indicate sensitivity to targeted therapies.
Purpose of the Study:
- To investigate IGF-1R expression in thymic malignancies.
- To correlate IGF-1R levels with clinical and pathological factors.
- To assess the potential for IGF-1R-targeted treatments.
Main Methods:
- Analyzed 63 thymic tumors (thymomas and thymic carcinomas) using immunohistochemistry for IGF-1R.
- Correlated IGF-1R expression with epidermal growth factor receptor (EGFR) and KIT expression.
- Examined patient outcomes and time to progression.
Main Results:
- Moderate to high IGF-1R expression was found in 86% of thymic carcinomas and 43% of thymomas.
- Higher IGF-1R staining correlated with increased EGFR expression.
- Tumor stage and histology were significant prognostic factors, but IGF-1R expression was not directly associated with time to progression.
Conclusions:
- A significant proportion of thymic malignancies exhibit moderate to high IGF-1R expression.
- While direct prognostic association was not found, these results support further investigation of anti-IGF-1R inhibitors.
- Lack of preclinical models limited functional studies of anti-IGF-1R therapy.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...